side effects of cjc-1295 no dac and ipamorelin Effects: Common Risks, Safety & When to Stop 2 Months on CJC-1295 (No

30 Second Summary of the difference between Sermorelin and Ipamorelin Sermorelin and Ipamorelin are the two commonly used peptides in peptide therapies

You May Also Like BPC 157+TB-500 CJC-1295 (No DAC)+ Ipamorelin Thymosin Alpha-1 Why Choose Forward Peptides

Miami Stem Cell offers the broadest menu with 30+ compounds

Injection burden Can mix into one syringe or use two Best for Asymmetric dosing or staggered cycling Cycle driver Compound-specific titration CJC-1295 (no DAC) Loading 100 mcg Frequency Once daily Maintenance 200-300 mcg Route SubQ Ipamorelin Loading 100 mcg Frequency Once daily Maintenance 200-300 mcg Route SubQ Weekly Schedule Example Monday CJC-1295 200 mcg + Ipamorelin 200 mcg Tuesday CJC-1295 200 mcg + Ipamorelin 200 mcg Wednesday CJC-1295 200 mcg + Ipamorelin 200 mcg Thursday CJC-1295 200 mcg + Ipamorelin 200 mcg Friday CJC-1295 200 mcg + Ipamorelin 200 mcg Saturday CJC-1295 200 mcg + Ipamorelin 200 mcg Sunday CJC-1295 200 mcg + Ipamorelin 200 mcg When mixing both peptides into a single syringe, draw each peptide separately and combine in the syringe

When prescribed and administered by a trained medical professional, CJC-1295 + Ipamorelin is safe and well-tolerated, with a reduced risk of side effects

They are independent of GHRH and may also reduce somatostatin inhibition